Mark Hopman sold $6K of BBNX stock

Mark Hopman, Chief Commercial Officer of Beta Bionics, Inc. (BBNX), sold 370 shares of BBNX stock worth $6K, per an SEC Form 4 filed Nov 4, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Nov 2, 2026, 2 days before it was made public.

BBNX has moved -1.3% since the trade date, from $15.90 to $15.70 (Nov 6, 2026 close).